Assays and kits for MSC-derived extracellular vesicles
Award amount
$1,646,328Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Cellarcus Biosciences, Inc.
- Proposal award date
- 2020-08-01
- Contract end date
- 2022-07-31
- UEI
- QUVQAKJFJCQ9
- Solicitation number
- PA19-272
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Quantitative Analysis of Cancer-associated EVs
- Identification of Cell Type-specific EVs for Neuroscience Research
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
3 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $5,089,417. Reported amounts are not federal obligations.
Phases: Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services